Resistant Hypertension Gets Personal: Aldosterone, Renin, and the Renewed Secondary Workup

Resistant Hypertension Gets Personal: Aldosterone, Renin, and the Renewed Secondary Workup Review Abstract Purpose: Resistant hypertension remains a significant clinical challenge and is associated with a markedly increased risk of cardiovascular disease, chronic kidney disease progression, stroke, heart failure, and premature mortality. Despite the availability of multiple

Albuminuria as a Vital Sign: Why Urine ACR Is Becoming Central to Kidney-Cardiovascular Risk Assessment

Albuminuria as a Vital Sign: Why Urine ACR Is Becoming Central to Kidney-Cardiovascular Risk Assessment Review Abstract Albuminuria, most commonly assessed using the urine albumin-to-creatinine ratio (ACR), has emerged as one of the most valuable biomarkers in contemporary nephrology and cardiovascular medicine. Despite its proven clinical

The Vitamin D Debate: From Universal Supplement to Precision Therapy

The Vitamin D Debate: From Universal Supplement to Precision Therapy Review Abstract Vitamin D supplementation has evolved from a simple solution to rickets into one of medicine’s most debated therapeutic interventions. This paper examines the current evidence surrounding vitamin D’s role in health and disease,

Chronic Kidney Disease in the Non-Diabetic Patient: What’s New and What Works?

Chronic Kidney Disease in the Non-Diabetic Patient: What’s New and What Works? Abstract Chronic kidney disease (CKD) represents a major global health challenge, affecting more than 850 million people worldwide and contributing substantially to cardiovascular morbidity, premature mortality, and escalating healthcare costs. Although diabetic kidney disease remains

Expert Guide: Managing Cardiovascular-Kidney-Metabolic Syndrome in Clinical Practice

Expert Guide Managing Cardiovascular-Kidney-Metabolic Syndrome in Clinical Practice Introduction Cardiovascular kidney metabolic syndrome represents one of the most urgent and complex health challenges of the modern era. The global burden of cardiovascular disease continues to rise at an alarming pace, with prevalence increasing from approximately

Why Brain Wearables Are Making Traditional EEG Labs Obsolete in 2025

Why Brain Wearables Are Making Traditional EEG Labs Obsolete in 2025   Introduction Brain wearables are reshaping the landscape of neurological monitoring at a time when epilepsy continues to affect approximately 70 million people worldwide, accounting for nearly one percent of the global population. Despite this high prevalence, access to

The Role of Plant-Based Diets in Slowing Chronic Kidney Disease Progression: An Analytical Review

The Role of Plant-Based Diets in Slowing Chronic Kidney Disease Progression: An Analytical Review   Abstract Background:Chronic kidney disease (CKD) affects more than 10% of the global population and is increasingly recognized as a critical public health challenge. Its rising prevalence is largely attributed to

Cholesterol Guidelines 2025: Should Age 40 Be the New Threshold for Statin Therapy?

Cholesterol Guidelines 2025: Should Age 40 Be the New Threshold for Statin Therapy?   Introduction Cardiovascular disease (CVD) remains the leading cause of death for most racial and ethnic groups, with cholesterol guidelines playing a crucial role in prevention strategies. Dyslipidemia stands

The Iron Truth: Are We Missing the Signs of Iron Overload? A Review of Hemochromatosis and Underdiagnosis in Practice

The Iron Truth: Are We Missing the Signs of Iron Overload? A Review of Hemochromatosis and Underdiagnosis in Practice  Please like and subscribe if you enjoyed this video :-) Abstract Hemochromatosis is a disorder characterized by the progressive accumulation of iron in

Anemia of Inflammation vs Iron Deficiency: New Diagnostic Tools and Therapies

Anemia of Inflammation vs Iron Deficiency Anemia: New Diagnostic Tools and Therapies Please like and subscribe if you enjoyed this video :-)   Abstract This paper provides a clear, up-to-date overview of how anemia of inflammation (AI) and iron deficiency anemia (IDA) differ,

Resistant Hypertension Gets Personal: Aldosterone, Renin, and the Renewed Secondary Workup